
ADMA Biologics, Inc.
USD8.59
-0.16 (-1.83%)
CEO
Adam S. Grossman
IPO Date
2013-10-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.69
Prev. Close
$8.75
Day Low
$8.58
Day High
$8.76
52W Low
$7.21
52W High
$20.46
Market Cap
$1.99B
Volume
2.58M
| 13 Apr 2026 |
| Mizuho |
| Outperform |
| Outperform |
| maintain |
| 26 Mar 2026 | Cantor Fitzgerald | Overweight | Neutral | downgrade |
| 8 May 2025 | Raymond James | Strong Buy | Strong Buy | maintain |
| 4 Mar 2025 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 8 Nov 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 8 Nov 2024 | Raymond James | Strong Buy | Strong Buy | maintain |
| 14 Oct 2024 | HC Wainwright & Co. | Buy | Buy | maintain |